Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rhogam and AIDS

Executive Summary

FDA and CDC have concluded that Ortho's plasma product for RH disease did not cause a woman, who had tested positive for AIDS, to become infected with the virus ("The Pink Sheet" Oct. 12 "In Brief"). The agencies determined that "the alcohol fractionation method used in preparing Rhogam would inactivate any virus that might be present and there are other, more likely sources of the AIDS virus for this woman." FDA and CDC recommend that facilities awaiting results of the investigation resume using Rhogam.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS012780

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel